Natural Biocon (India) Ltd (543207)
Latest quarterly results (Q4 FY26)
In its latest reported quarter, Q4 FY26, Natural Biocon's revenue was ₹0.9 Cr (-34.8% year on year), and net profit ₹-0.1 Cr (a smaller loss than a year earlier); the operating margin was -10.2%.
| Q4 FY26 (₹ Cr) | Value | YoY vs Q4 FY25 | QoQ |
|---|---|---|---|
| Revenue | ₹0.9 | -34.8% | — |
| Operating profit | ₹-0.1 | loss narrowed | loss widened |
| Net profit | ₹-0.1 | loss narrowed | loss widened |
| EPS (₹) | -0.03 | loss narrowed | loss widened |
| Operating margin | -10.2% | — | — |
📢 Recent Corporate Announcements
Natural Biocon (India) Ltd announced that its Board of Directors accepted the resignations of Managing Director Arunkumar Dashrathbhai Prajapati and Company Secretary Shruti Sharma, both effective retrospectively from September 26, 2026. Additionally, the Board decided to cancel and withdraw previous disclosures regarding the appointments of two Independent Directors (effective June 6, 2026) and the AGM Scrutinizer. This leadership vacuum hits a micro-cap company with a market cap of just Rs 5 Cr and a declining revenue base (FY26 revenue fell to Rs 2.55 Cr with an annual net loss of Rs 0.03 Cr).
- Resignation of Managing Director Arunkumar Dashrathbhai Prajapati effective 26 September 2026
- Resignation of Company Secretary Shruti Sharma effective 26 September 2026
- Cancellation/withdrawal of appointments for 2 Additional Independent Directors originally effective 06 June 2026
- Withdrawal of disclosure regarding appointment of Scrutinizer for AGM e-voting
- Micro-cap context: market capitalization stands at Rs 5 Cr with FY26 revenue of Rs 2.55 Cr
Natural Biocon (India) Ltd announced that its Managing Director, Arun Kumar Dashrathbhai Prajapati, has resigned from the board effective close of business hours on September 26, 2026. The cited reason is increased professional commitments and time constraints, with no other material reasons reported. The departing Managing Director holds NIL shares in the micro-cap company (market cap Rs 5 Cr). This leadership exit occurs as the company operates at a modest scale, generating TTM revenue of just Rs 3 Cr.
- Managing Director Arun Kumar Dashrathbhai Prajapati resigned with effect from September 26, 2026
- Reason cited is increased professional commitments and time constraints
- Outgoing Managing Director holds NIL shares in the company
- Departure comes amidst micro-cap scale with Rs 5 Cr market cap and TTM revenue of Rs 3 Cr
Natural Biocon (India) Ltd announced the outcome of its Board meeting held on September 05, 2026. The Board approved convening the 34th Annual General Meeting (AGM) on September 30, 2026, via Video Conferencing, with share transfer books closed from September 24 to September 30, 2026. Additionally, the Board formalized the appointment of two Additional Independent Directors (Mrs. Tapasya Sheth and Mrs. Minaben Shah) and accepted the resignation of Company Secretary Mr. Gopal Trivedi, all effective June 06, 2026.
- 34th Annual General Meeting scheduled for September 30, 2026, at 11:30 AM IST via VC
- Share transfer books and Register of Members to remain closed from September 24 to September 30, 2026
- Appointed Mrs. Tapasya Sheth and Mrs. Minaben Shah as Non-Executive Independent Directors w.e.f. June 06, 2026
- Noted resignation of Mr. Gopal Trivedi as Company Secretary and Compliance Officer w.e.f. June 06, 2026
Natural Biocon (India) Ltd reported zero operational revenue for the quarter ended June 30, 2026, down from ₹166.57 lakh in the corresponding quarter of the previous year. The company posted a net loss of ₹1.16 lakh compared to a net profit of ₹13.86 lakh in Q1 FY26. Total expenses declined sharply to ₹1.16 lakh (vs ₹152.71 lakh in Q1 FY26) due to the absence of trading and purchase activity. Additionally, the board approved the resignation of statutory auditor M/s Mayur Shah & Associates and appointed M/s Nirav S Shah & Co.
- Revenue from operations was ₹0.00 lakh vs ₹166.57 lakh in Q1 FY26
- Net loss stood at ₹1.16 lakh against a net profit of ₹13.86 lakh in Q1 FY26
- Total expenses dropped to ₹1.16 lakh compared to ₹152.71 lakh in the previous year quarter
- Paid-up equity share capital stood unchanged at ₹2,578.28 lakh
- M/s Nirav S Shah & Co appointed as Statutory Auditors w.e.f. August 1, 2026 following resignation of M/s Mayur Shah & Associates
Natural Biocon (India) Ltd reported zero revenue from operations for the quarter ended June 30, 2026, down sharply from Rs 1.67 Cr (Rs 166.57 Lakhs) in Q1 FY26 and Rs 0.88 Cr in Q4 FY26. The company posted a net loss of Rs 1.16 Lakhs against a net profit of Rs 13.86 Lakhs in the corresponding quarter of the previous year. Total expenses dropped to Rs 1.16 Lakhs due to lack of trading activity. Additionally, the Board approved the resignation of statutory auditor M/s Mayur Shah & Associates and appointed M/s Nirav S Shah & Co.
- Revenue from operations fell to Rs 0.00 Lakhs in Q1 ended June 30, 2026, compared to Rs 166.57 Lakhs in Q1 FY26.
- Net loss recorded at Rs 1.16 Lakhs versus a net profit of Rs 13.86 Lakhs in Q1 FY26.
- Total expenses stood at Rs 1.16 Lakhs, driven by Rs 1.06 Lakhs in other expenses and Rs 0.10 Lakhs in depreciation.
- Resignation of Statutory Auditor M/s Mayur Shah & Associates effective July 31, 2026, and appointment of M/s Nirav S Shah & Co effective August 1, 2026.
Natural Biocon (India) Ltd has scheduled a board meeting for August 14, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. A significant agenda item is the resignation of the current statutory auditors, M/s Mayur Shah & Associates, and the proposed appointment of M/s Nirav S Shah & Co. Given the company's micro-cap status (Rs 7 Cr) and low promoter holding of 9.4%, the reasons behind the auditor change are critical for investors to monitor. The company reported a revenue of Rs 2.55 Cr in FY26, a sharp decline from Rs 8.35 Cr in FY25.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results
- Resignation of M/s Mayur Shah & Associates as Statutory Auditors to be noted
- Proposed appointment of M/s Nirav S Shah & Co as the new Statutory Auditors
- Company market capitalization stands at a low Rs 7 Cr
- Promoter holding is notably low at 9.4% as of March 2026
Natural Biocon (India) Ltd has announced the immediate resignation of two directors, Mrs. Tapasya Sheth and Mrs. Minaben Shah, effective July 14, 2026. The board meeting to approve these exits was conducted and concluded within 45 minutes. This management change occurs against a backdrop of significant share price erosion, with the stock down 70.3% over the last 12 months. No specific reasons for the resignations were disclosed in the filing.
- 2 directors, Mrs. Tapasya Sheth and Mrs. Minaben Shah, resigned effective July 14, 2026
- The board meeting lasted 45 minutes, starting at 12:00 p.m. and concluding at 12:45 p.m.
- Company stock has experienced a 70.3% price decline over the past 12 months
- The resignations were accepted and approved in the board meeting held on July 14, 2026
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
